Summary & Overview
HCPCS G8601: IV Thrombolytic Not Initiated Within 4.5 Hours
HCPCS Level II code G8601 documents cases where intravenous thrombolytic therapy for acute ischemic stroke was not started within 4.5 hours (≤ 270 minutes) of the time the patient was last known well, for clinician-documented reasons such as trial enrollment or planned carotid procedures. Nationally, clear documentation of treatment decisions and timing is central to quality measurement, performance benchmarking, and payer adjudication for acute stroke care.
Key payers covered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical meaning, typical sites of service (hospital inpatient and emergency department), and the service type tied to acute stroke thrombolysis decision-making and documentation. The publication outlines common modifiers used with this code, discusses implications for claims review and coding compliance, and highlights where this code fits within stroke performance measurement and billing workflows.
This summary provides clinicians, coders, and billing professionals with the context needed to recognize when G8601 applies, what documentation elements are relevant, and which payers are commonly involved in coverage and claims review nationally. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G8601 indicates that intravenous thrombolytic therapy was not initiated within 4.5 hours (≤ 270 minutes) of time last known well for reasons documented by the clinician. Examples in the code descriptor include situations such as patient enrollment in a clinical trial for stroke or patient admitted for elective carotid intervention.
Service type: Acute stroke thrombolysis decision/documentation
Typical site of service: Hospital inpatient or emergency department
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 72-year-old male with history of hypertension and atrial fibrillation is brought to the emergency department after acute onset right-sided weakness and aphasia noted by family. Time last known well is 6 hours prior to arrival. Initial stroke evaluation includes noncontrast head CT to exclude hemorrhage, NIH Stroke Scale assessment, and vascular imaging. The treating neurologist documents that IV thrombolytic therapy (alteplase) is clinically indicated but not initiated within 4.5 hours (≤270 minutes) of time last known well because the patient is enrolled in a randomized clinical trial evaluating an investigational neuroprotective agent for acute ischemic stroke. The clinician documents the reason for non-initiation in the medical record, including time last known well, contraindications considered, and trial enrollment details. Typical workflow steps include ED triage and stroke activation, urgent imaging (CT/CTA), laboratory evaluation including coagulation studies, neurology consultation, shared decision-making or documentation of trial consent, and inpatient admission for stroke management or preparation for an elective carotid intervention if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when services required substantially greater work than typical, documented and justified by clinician notes. |